BioAtla (BCAB) Interest Coverage Ratio (2020 - 2026)
BioAtla's (BCAB) quarterly Interest Coverage Ratio came in at 465.4 in Q1 2026, down 660.96% year-on-year from 82.97 in Q1 2025, and down 5371.12% quarter-over-quarter from 8.51 in Q3 2025.
BioAtla (BCAB) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
BioAtla's Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 465.4 for Q1 2026.
- On a quarterly basis, Interest Coverage Ratio fell 660.96% year-over-year to 465.4 in Q1 2026; TTM through Mar 2026 was 51.57, a 5.21% decrease from a year earlier, with the FY2025 full-year figure at 0.51, up 28.98% from the prior year.
- Interest Coverage Ratio retreated to 465.4 in Q1 2026 per BCAB's latest filing, from 8.51 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.01 in Q3 2022 and bottomed at 3248.8 in Q4 2024.
- The 5-year median for Interest Coverage Ratio is 27.21 (2024), against an average of 260.1.
- Across the five-year window, Interest Coverage Ratio soared 99.99% in 2022 and slumped 432668.98% in 2023, its largest moves.
- Year by year, Interest Coverage Ratio stood at 71.4 in 2022, then plunged by 45.86% to 104.15 in 2023, then slumped by 3019.47% to 3248.8 in 2024, then jumped by 99.74% to 8.51 in 2025, then sank by 5371.12% to 465.4 in 2026.
- Per Business Quant, the three latest BCAB Interest Coverage Ratio figures stand at 465.4 (Q1 2026), 8.51 (Q3 2025), and 2.37 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | BioAtla | 5.74 Mn | 5.74 Mn | - | -465.40 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -465.40 |
| Sep 30, 2025 | -8.51 |
| Jun 30, 2025 | -2.37 |
| Mar 31, 2025 | -61.16 |
| Dec 31, 2024 | -3,248.80 |
| Sep 30, 2024 | -8.87 |
| Jun 30, 2024 | -12.97 |
| Mar 31, 2024 | -0.05 |
| Dec 31, 2023 | -104.15 |
| Sep 30, 2023 | -41.44 |
| Jun 30, 2023 | -0.38 |
| Mar 31, 2023 | -71.08 |
| Dec 31, 2022 | -71.40 |
| Sep 30, 2022 | -0.01 |
| Jun 30, 2022 | -0.47 |
| Mar 31, 2022 | -64.58 |
| Dec 31, 2021 | -63.31 |
| Sep 30, 2021 | -64.04 |
| Jun 30, 2021 | -2.00 |
| Mar 31, 2021 | -59.48 |